<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The DNA methyltransferase 3A (DNMT3A) -448A&gt;G polymorphism is a novel functional single nucleotide polymorphism (SNP) that contributes to the genetic susceptibility to <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we aimed to assess the genotype frequencies of DNMT3A -448A&gt;G in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients and healthy control subjects, and to explore the association of the DNMT3A functional SNP, -448A&gt;G, with genetic susceptibility to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Genomic DNA was extracted from samples of 258 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and 280 healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>Polymerase chain reaction-restriction fragment length polymorphism analysis was employed to assess the genotype frequencies of DNMT3A -448A&gt;G in <z:hpo ids='HP_0000001'>all</z:hpo> of the subjects </plain></SENT>
<SENT sid="4" pm="."><plain>Stratification analyses were used to study subgroups of subjects by age and gender, and to evaluate the association between the DNMT3A -448A&gt;G polymorphism and the genetic susceptibility to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The allele frequency of -448A among <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients and the controls was 26.4 versus 19.8%, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Overall, we found that compared with GG carriers, the DNMT3A -448AA homozygotes had a 3.692-fold increased risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Stratification analysis showed a significant difference in this SNP between the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients and the control subjects of different genders </plain></SENT>
<SENT sid="8" pm="."><plain>AA homozygotes carried an increased risk in the subgroup of individuals aged ≥50 years in male <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Compared with GG homozygotes in females aged ≥50 years, the AG and AA genotypes carried a 0.355-fold decreased risk in this subgroup </plain></SENT>
<SENT sid="10" pm="."><plain>These data imply that the DNMT3A SNP -448A&gt;G contributes to genetic susceptibility to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>-448A&gt;G may be used as a stratification marker to predict the susceptibility of certain individuals to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, particularly in male individuals aged ≥50 years </plain></SENT>
</text></document>